| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: pierre.blanchard@gustaveroussy.fr. Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. Radiation Oncology, Centre Francois Baclesse, Caen, France. Radiation Oncology, Institut Paoli Calmette Marseille, France. Radiation Oncology, Institut de Cancerologie de l'Ouest, Angers, France. Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. Medical Oncology, Institut de Cancerologie de l'Ouest, Nantes, France. Medical Oncology, Centre Antoine Lacassagne, Nice, France. Medical Oncology, Institut Bergonie, Bordeaux, France. Institut Claudius Regaud, Toulouse, France. Hospital Foch, Suresnes, France. Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. Clinique Sainte Marguerite, Hyeres, France. Centre Hospitalier de la Timone, Marseille, France. Centre Eugene Marquis, Rennes, France. Clinique Sainte Catherine, Avignon, France. R&D UNICANCER, Paris, France; UNICANCER, Paris, France. Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. alt-title: International journal of radiation oncology, biology, physics accession-num: 26576711 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial |
Institut de Recherche en Cancérologie de
